REQUEST A DEMO
Total
USD $0.00
Search more companies

Evrogen ZAO (Russia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Evrogen ZAO Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Evrogen ZAO is an enterprise located in Russia, with the main office in Moscow. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. It was incorporated on July 25, 2002. The company’s latest financial report indicates a net sales revenue drop of 4.53% in 2023. There was a total negative growth of 8.89% in Evrogen ZAO’s total assets over the same period. The enterprise’s net profit margin decreased by 13.45% in 2023.

Headquarters
Mikluho-Maklaya, 16/10, 22-32, Komn. 4
Moscow; Moscow; Postal Code: 117871

Contact Details: Purchase the Evrogen ZAO report to view the information.

Website: http://rjbc.ru

Basic Information
Outstanding Shares:
Purchase the Evrogen ZAO report to view the information.
Registered Capital:
Purchase the Evrogen ZAO report to view the information.
Incorporation Date:
July 25, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Medtehklaster Yuzhnyi
Company Performance
Financial values in the chart are available after Evrogen ZAO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-4.53%
Total operating revenue
-4.53%
Operating profit (EBIT)
-27.94%
Net Profit (Loss) for the Period
-23.05%
Total assets
-8.89%
Total equity
-8.46%
Operating Profit Margin (ROS)
-16.12%
Net Profit Margin
-13.45%
Return on Equity (ROE)
-13.35%
Quick Ratio
0.07%
Cash Ratio
-0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?